Latest News about GSK
Recent news which mentions GSK
How Its New Vaccine Could Propel GSK's Growth
July 11, 2022
From Motley Fool
How to Earn $10,000 a Year in Passive Retirement Income
July 10, 2022
From Motley Fool
2 First-Rate ETFs for Stock Dividends
July 03, 2022
From Motley Fool
7 Retirement Stocks to Buy in July
July 01, 2022
From InvestorPlace
Ideaya Nominates Potential First-In-Class Pol Theta Helicase Inhibitor In Collaboration With GSK
June 28, 2022
From Benzinga
From Benzinga
How Pfizer Plans to Unlock Another Mass-Market Vaccine
June 27, 2022
From Motley Fool
From Benzinga
Why Sanofi May Be a Frontrunner in Endemic COVID-19
June 25, 2022
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
This Pharmaceutical Company Is Moving Beyond CBD
June 23, 2022
From Benzinga
From MarketWatch
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
What Could a Recession Mean for Healthcare Stocks?
June 09, 2022
From Motley Fool
From Benzinga
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
June 05, 2022
From Benzinga
From InvestorPlace
3 Undervalued Dividend Growth Stocks
June 01, 2022
From InvestorPlace
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.